Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Lost Money on Moderna, Inc. (MRNA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
11:15am, Tuesday, 17'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 17, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
Moderna Inc Is Being Sued For Possible Securities Law Violations And Affected Shareholders Should Contact The Schall Law Firm
11:00am, Tuesday, 17'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna" or
SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians this fall and winter season. Moderna will promptly begin deliv
Shareholders of Moderna, Inc. Should Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA
11:00am, Tuesday, 17'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 17, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Moderna To Contact Him Directly To Discuss Their Options If you su
Moderna, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA
07:15am, Tuesday, 17'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 17, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
NEW YORK CITY, NY / ACCESSWIRE / September 17, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Modern
NEW YORK , Sept. 17, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA) of a class action securities lawsuit.
Shareholders that lost money on Moderna, Inc.(MRNA) should contact Levi & Korsinsky about pending Class Action - MRNA
09:15pm, Monday, 16'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 16, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 8, 2024 in Moderna Lawsuit - MRNA
08:15pm, Monday, 16'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 16, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
Moderna (MRNA) Rises Higher Than Market: Key Facts
06:57pm, Monday, 16'th Sep 2024
The latest trading day saw Moderna (MRNA) settling at $69.17, representing a +1.3% change from its previous close.
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit
05:52pm, Monday, 16'th Sep 2024
NEW YORK , Sept. 16, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) between January 18, 2023 and June 25
Moderna, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - MRNA
04:50pm, Monday, 16'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 16, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
NEW YORK, NY / ACCESSWIRE / September 16, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, f
